Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Clinical trial NCT00399113 · COMPLETED

Trial details

NCT number: NCT00399113
Sponsor: Pain Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2007-05-01
Primary completion: 2008-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.